Related Experiment Video
Updated: Jan 10, 2026

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
Published on: March 22, 2017
From reporting to relating: Reimagining ePROMs in cancer symptom management
Karen S Schaepe1, Joan M Griffin2, Jennifer L Ridgeway2
1Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA, 200 First Street SW, Rochester, 55905, MN, USA.
Abstract:
Electronic Patient-Reported Outcome Measures (ePROMs) are digital tools that allow patients to report symptoms using computers, tablets, or smartphones. In cancer care, ePROMs are increasingly used to monitor SPPADE symptoms: sleep disturbance, pain, physical function decline, anxiety, depression, and energy deficit or fatigue. While ePROMs can support timely symptom recognition and clinical response, their influence on how patients and clinicians connect and understand one another during care remains notably underexplored. This study investigates how the integration of digital symptom reporting into clinical routines may shape both the content of symptom reporting and the relational dynamics between patients and providers. We conducted 46 in-depth interviews with cancer patients enrolled in a multi-year symptom management trial (E2C2) at Mayo Clinic. Using a combination of deductive frame analysis and inductive analysis informed by Boundary Object Theory, we first examined how patients with advanced cancer understood and approached the sharing of SPPADE symptoms. We then explored how ePROM technology shaped their experiences and perceptions of symptom reporting. We found that three interrelated factors shaped patient engagement with ePROMs: (1) personal orientations toward perceiving and expressing symptoms, (2) coping styles, including tensions between appropriate self-monitoring and positive self-presentation, and (3) expectations shaped by prior interactions with the care team. While ePROMs helped patients articulate symptoms, they also raised questions about whether responses were reviewed and how they were interpreted by clinicians. Patients described ePROMs as signaling what kinds of symptoms "counted" to providers, subtly reshaping their understanding of illness and their role in managing it. Our findings engage and extend Boundary Object Theory by showing that ePROMs function not only as tools for coordinating information, but also as relational artifacts. Attending to their interpretive and emotional effects highlights new opportunities to design systems that support connection and shared understanding, alongside efficient data flow.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Targeted Cancer Therapies
There are several types of targeted therapies against...

